finance
Analysts Lower Price Targets on Avista, Lennar, Globus Medical
Barclays, Wells Fargo, and Piper Sandler reduced price targets on three companies while keeping existing ratings. The adjustments followed Friday closing prices above the new targets.
BenzingaAudio version
Tap play to generate a narrated version.
Developing·Limited corroboration so far. This page will refresh as more sources emerge.
Barclays reduced its price target on Avista Corp from $42 to $39 and kept an Equal-Weight rating. Avista shares closed at $42.43 on Friday.
Wells Fargo cut its price target on Lennar Corporation from $90 to $85 and maintained an Equal-Weight rating. Lennar shares closed at $90.27 on Friday. Piper Sandler lowered its price target on Globus Medical from $115 to $100 and kept an Overweight rating.
Globus Medical shares closed at $80.39 on Friday. The changes were among analyst rating updates published for Monday trading.
Transparency
1 source · single source
CorroborationLimited · 1 source
